— During the fourth quarter of 2014, Cellular Dynamics
International, Inc. reported an increase in revenue of
The Madison-based developer and producer of fully
functioning human cells in industrial quantities
reported its total revenues for the fourth quarter of
2014 were $6.6 million compared to $4.2 million for the
fourth quarter of 2013. For the year ended Dec. 31,
2014, total revenues were $16.7 million compared to
$11.9 million for the year ended Dec. 31, 2013, an
increase of 40 percent.
Cellular Dynamics credits the growth for both periods to
an increase in collaborations, partnerships and other
revenues, which during the fourth quarter were $4
million compared to $1.7 million for the fourth quarter
of 2013, an increase of 139 percent.
Net loss for the fourth quarter of 2014 was $5.8
million, or $0.36 per share, compared with a net loss of
$6.7 million, or $0.43 per share, for the fourth quarter
of 2013, according to the report. For 2014, net loss was
$30.6 million, or $1.94 per share, compared with a net
loss of $25.0 million, or $3.17 per share, for 2013.
“A growing number of pharmaceutical, biotech and CRO
companies, as well as academic researchers continue to
adopt CDI’s products for their research programs. … We
believe these results add to the growing evidence that
we are the industry standard for manufactured human
cells,” said Bob Palay, chairman and CEO of CDI, in a
In 2014, CDI sold to 200 customers, up from 150 in 2013.
The company’s top 10 customers averaged $1.1 million in
revenue for 2014 and increase of 33 percent from
$830,000 in 2013, according to the report.